Literature DB >> 17373677

Cytokine gene polymorphisms in acquired bone marrow failure.

Vinod Gidvani1, Shakti Ramkissoon, Elaine M Sloand, Neal S Young.   

Abstract

Some acquired aplastic anemia (AA) results from immune-mediated destruction of hematopoietic stem cells. Cytokine gene polymorphisms are implicated in controlling cytokine production and increasing the susceptibility to some autoimmune diseases. We characterized the IL-6/-174, TNF-alpha/-308, IL-10/-1082, IFN-gamma/+874, TGFbeta1/-509 single nucleotide polymorphisms (SNP's) and the IL1-RA second intron variable number tandem repeat (VNTR) alleles in 73 patients with AA and compared the frequency of genotypes to established control populations. We found that some patients with acquired AA have polymorphisms which are linked to high production of proinflammatory cytokines, particularly TNF-alpha and IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17373677     DOI: 10.1002/ajh.20881

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  14 in total

Review 1.  How I treat acquired aplastic anemia.

Authors:  Phillip Scheinberg; Neal S Young
Journal:  Blood       Date:  2012-04-19       Impact factor: 22.113

2.  TRAIL in CD8+ T cells from patients with severe aplastic anemia.

Authors:  Chunyan Liu; Mengying Zheng; Tian Zhang; Rong Fu; Huaquan Wang; Ting Wang; Weiwei Qi; Zonghong Shao
Journal:  Int J Hematol       Date:  2017-06-19       Impact factor: 2.490

Review 3.  The diagnosis and treatment of aplastic anemia: a review.

Authors:  Maurizio Miano; Carlo Dufour
Journal:  Int J Hematol       Date:  2015-04-03       Impact factor: 2.490

4.  Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010.

Authors:  Michael A Pulsipher; Neal S Young; Jakub Tolar; Antonio M Risitano; H Joachim Deeg; Paolo Anderlini; Rodrigo Calado; Seiji Kojima; Mary Eapen; Richard Harris; Phillip Scheinberg; Sharon Savage; Jaroslaw P Maciejewski; Ramon V Tiu; Nancy DiFronzo; Mary M Horowitz; Joseph H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2010-10-27       Impact factor: 5.742

Review 5.  The complex pathophysiology of acquired aplastic anaemia.

Authors:  Y Zeng; E Katsanis
Journal:  Clin Exp Immunol       Date:  2015-04-23       Impact factor: 4.330

6.  Th17 immune responses contribute to the pathophysiology of aplastic anemia.

Authors:  Regis Peffault de Latour; Valeria Visconte; Tomoiku Takaku; Colin Wu; Andrew J Erie; Annahita K Sarcon; Marie J Desierto; Phillip Scheinberg; Keyvan Keyvanfar; Olga Nunez; Jichun Chen; Neal S Young
Journal:  Blood       Date:  2010-08-23       Impact factor: 22.113

7.  Common polymorphic deletion of glutathione S-transferase theta predisposes to acquired aplastic anemia: Independent cohort and meta-analysis of 609 patients.

Authors:  Daria V Babushok; Yimei Li; Jacquelyn J Roth; Nieves Perdigones; Joshua D Cockroft; Jaclyn A Biegel; Philip J Mason; Monica Bessler
Journal:  Am J Hematol       Date:  2013-07-23       Impact factor: 10.047

Review 8.  Aplastic anemia.

Authors:  Neal S Young; Phillip Scheinberg; Rodrigo T Calado
Journal:  Curr Opin Hematol       Date:  2008-05       Impact factor: 3.284

9.  Association of Interleukin-1β-31C/T, -511T/C and -3954C/T Single Nucleotide Polymorphism and Their Blood Plasma Level in Acquired Aplastic Anemia.

Authors:  Saurabh Shukla; Anil Kumar Tripathi; Shailendra Prasad Verma; Deependra Kumar Yadav; R K Tripathi; Shweta Maurya; Nidhi Awasthi
Journal:  Indian J Hematol Blood Transfus       Date:  2020-04-26       Impact factor: 0.900

Review 10.  Genetic associations in acquired immune-mediated bone marrow failure syndromes: insights in aplastic anemia and chronic idiopathic neutropenia.

Authors:  Irene Mavroudi; Helen A Papadaki
Journal:  Clin Dev Immunol       Date:  2012-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.